Cargando…

OR10-2 A Modifying Autoantigen in Graves' Disease

In patients with Graves’ disease (GD), previous studies have associated SNPs in linkage disequilibrium with the TSHR gene locus with changes in expression of two TSH receptor (TSHR) variants suggesting that receptor variants may have an important role in disease etiology. Bioinformatic analyses pred...

Descripción completa

Detalles Bibliográficos
Autores principales:	Latif, Rauf, Mezei, Mihaly, Morshed, Syed, Ma, Risheng, Ehrlich, Rachel, Davies, Terry
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Endocrine Society 2019
Materias:	Thyroid
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554773/ http://dx.doi.org/10.1210/js.2019-OR10-2

Ejemplares similares

OR03-06 Transmembrane Water Channels Within The Tsh Receptor
por: Latif, Rauf, et al.
Publicado: (2023)

SAT-558 Tsh Modulation Of Bone Biology - Further Evidence From A Recombinant Tsh-β Variant.
por: Baliram, Ramkumarie, et al.
Publicado: (2019)

A Gq Biased Small Molecule Active at the TSH Receptor
por: Latif, Rauf, et al.
Publicado: (2020)

Brief Report - Monoclonal Antibodies Illustrate the Difficulties in Measuring Blocking TSH Receptor Antibodies
por: Davies, Terry F., et al.
Publicado: (2022)

At Last the Explanation for Increased Spontaneous Miscarriages in Thyroid Autoantibody Positive Pregnant Women
por: Behringer-Massera, Stephanie, et al.
Publicado: (2021)

PSAT316 Thyroid Storm Triggered by Coronavirus Disease-19 (COVID-19) In a Patient With Graves’ Disease
por: Rauf, Mohammad Uzair Abdul, et al.
Publicado: (2022)

Graves Disease in Infancy
por: Beliard, Kara A, et al.
Publicado: (2021)

A Grave Initial Presentation of Graves’ Disease in a Patient With Moyamoya
por: Clutter, Courtney, et al.
Publicado: (2021)

Thyroid Cell Differentiation from Murine Induced Pluripotent Stem Cells
por: Ma, Risheng, et al.
Publicado: (2015)

A Stem Cell Surge During Thyroid Regeneration
por: Ma, Risheng, et al.
Publicado: (2021)

PSAT358 Graves’ Disease Complicated by Post-Operative Graves’ Ophthalmopathy and Pretibial Myxedema
por: Bowens, Brendan, et al.
Publicado: (2022)

SUN-525 Successful Surgical Management of Graves’ Disease in Pregnancy
por: Ali, Dalal, et al.
Publicado: (2020)

SAT461 Hearing-related Issues Associated With Graves’ Disease, Thyroid Eye Disease And Treatment With Teprotumumab
por: Smith, Terry J, et al.
Publicado: (2023)

An Unusual Etiology of Graves’ Disease: Alemtuzumab
por: Santiago Carrion, Ada Marie, et al.
Publicado: (2021)

Presentation and Outcome of Severe Graves’ Disease
por: Babu, Priya Mohan, et al.
Publicado: (2021)

Graves’ Disease Induced Severe Hypercalcemia
por: Lugo Lopez, Zahira Marie, et al.
Publicado: (2021)

SUN-567 Moyamoya and Autoimmune Graves' Disease
por: Elagi, Daniyah, et al.
Publicado: (2019)

SAT-476 Alemtuzumab Induced Graves Disease
por: Caputi, Rafael C, et al.
Publicado: (2020)

SAT489 Grave’s Disease Secondary To Alemtuzumabuse
por: Gong, Michael Shifeng, et al.
Publicado: (2023)

SAT-554 Teprotumumab in Graves' Orbitopathy: Extended Outcome Analyses
por: Kahaly, George, et al.
Publicado: (2019)

Computational model of the full-length TSH receptor
por: Mezei, Mihaly, et al.
Publicado: (2022)

A Grave Turn on Hashimoto’s Thyroiditis - A Case Series on Four Patients With Autoimmune Hypothyroidism that Converted to Grave’s Disease
por: Lee, Michelle N, et al.
Publicado: (2021)

Early Biochemical Response to Antithyroid Drugs in Graves’ Disease: The Role of Initial Dosing
por: El Kawkgi, Omar M, et al.
Publicado: (2021)

FRI565 Spontaneous Conversion Of Long-standing Hypothyroidism To Grave’s Disease: A Case Report
por: Rose Dominic, Maria, et al.
Publicado: (2023)

Treatment of Graves’ Disease With a Combination of Low Iodine Diet and Potassium Iodide Plus Radioactive Iodine Treatment
por: Ebrahim, Ismail, et al.
Publicado: (2021)

SAT-603 Graves' Disease and an Anterior Mediastinal Mass
por: Robbins, D'lorah, et al.
Publicado: (2019)

SAT-592 Amiodarone-Induced Cure Of Graves' Disease
por: Sharma, Eliza, et al.
Publicado: (2019)

SAT-605 Immune Thrombocytopenic Purpura in Graves' disease
por: Sajja, Puspalatha, et al.
Publicado: (2019)

SAT-582 Autoimmune Hepatitis Presenting with Graves Disease
por: Coy, Andres, et al.
Publicado: (2019)

FRI567 Insulin Autoimmune Syndrome And Grave’s Disease
por: Skariah, Annie M, et al.
Publicado: (2023)

SAT-423 Anti-thyroid Drug Response in Graves’ Disease: Predictors of Biochemically Persistent Disease
por: El Kawkgi, Omar M, et al.
Publicado: (2020)

Stemness is Derived from Thyroid Cancer Cells
por: Ma, Risheng, et al.
Publicado: (2014)

Derivation and 97% Purification of Human Thyroid Cells From Dermal Fibroblasts
por: Ma, Risheng, et al.
Publicado: (2020)

Long Term Rescue of the TSH Receptor Knock-Out Mouse – Thyroid Stem Cell Transplantation Restores Thyroid Function
por: Latif, Rauf, et al.
Publicado: (2021)

MON-594 Report Of A Large Series Of Patients With Graves' Disease (with/without Graves' Ophthalmopathy) And Review Of The Literature, About The Association With Other Autoimmune Diseases
por: Ferrari, Silvia Martina, et al.
Publicado: (2019)

PSAT345 Neonatal Graves (NG) Affecting 3 Newborns of a Mother Treated with Radioactive Iodine (RAI) for Graves’ Disease (GD)
por: Ali, Dalal S, et al.
Publicado: (2022)

SUN-560 Thyrotoxic Hashimoto's Disease: Is It Graves' Thyrotoxicosis or "Hashitoxicosis"?
por: Baral, Neelam, et al.
Publicado: (2019)

SUN-571 Thymic Hyperplasia: An Unusual Manifestation of Graves’ Disease
por: Agarwal, Priyanka, et al.
Publicado: (2019)

SUN-622 Graves Disease Triggered by Lobectomy for Thyroid Cancer
por: Woods, Allison, et al.
Publicado: (2019)

SAT-428 Sex-Specific Risk Gene of Graves’ Disease
por: Zhao, Shuangxia, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_0nn7um9vaq3mfubnutvobovnr0